MBM Wealth Consultants’s CryoPort CYRX Stock Holding History

MBM Wealth Consultants’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-128	Closed	-$2K	–	295
2022 Q4	$2K	Buy	+128	New	+$2.7K	﹤0.01%	307

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

MBM Wealth Consultants's CYRX Position: Q1 2023 in Review

MBM Wealth Consultants sold out of CryoPort (CYRX) in Q1 2023, closing a stake of 128 shares — an estimated $2K sold.

MBM Wealth Consultants first reported a position in CYRX in Q4 2022 and held it in 1 quarter. The position peaked at $2K in Q4 2022. 178 funds tracked by Wall St. Rank hold CYRX as of Q1 2023.

MBM Wealth Consultants reported no remaining CryoPort position as of Q1 2023 after selling out during the quarter.
MBM Wealth Consultants sold 128 CryoPort shares in Q1 2023, an estimated $2K.
MBM Wealth Consultants first reported a position in CryoPort in Q4 2022 and held it in 1 quarter.
MBM Wealth Consultants's CryoPort position peaked at $2K in Q4 2022.
178 funds tracked by Wall St. Rank held CryoPort as of Q1 2023.

Based on MBM Wealth Consultants's 13F filing for Q1 2023, filed 31 May 2023.